#AI Robot in Heart Treatment Market Growth

[lalsingh228-blog]

AI Robot in Heart Treatment Market Set for Explosive Growth

Advance Market Analytics published a new research publication on "AI Robot in Heart Treatment Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the AI Robot in Heart Treatment market was mainly driven by the increasing R&D spending across the world.

Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/186484-global-ai-robot-in-heart-treatment--market The AI Robot in Heart Treatment Market report covers extensive analysis of the key market players, along with their business overview, expansion plans, and strategies. The key players studied in the report include: Heartlander Surgical (United States), Intuitive Surgical (United States), Medrobotics Corporation (United States), CMR Surgical Limited (United Kingdom), Corindus Vascular Robotics (United States), Hansen Medical (United States) Definition: AI robots are rapidly growing in popularity in the medical to perform various clinical tasks and surgeries. Growing preference towards minimally invasive surgery and emerging trends of remote surgery across the healthcare sector will accelerate the growth of AI robots in heart treatment. Most surgical robots have a camera that captures real-time images and videos and sends them to the monitor in the surgical room to guide doctors during surgery. The following fragment talks about the AI Robot in Heart Treatment market types, applications, End-Users, Deployment model etc. A thorough analysis of AI Robot in Heart Treatment Market Segmentation: by Type (Rehabilitation Robots, Surgical Robots), Application (Cardiac Ablation, Myocardial Regeneration, Biventricular Pacing Lead Placement, Valve Repair, Removal of Cardiac Tumors, Others), Dimensional Type (2D, 3D), End-user (Electrophysiologists, Interventional Cardiologists, Cardiothoracic Surgeons, Government Hospitals, Rehabilitation Centers, Others) AI Robot in Heart Treatment Market Drivers:

Surging Demand for AI Robots in the Heart Surgery to Reduce the Surgery Timing and Patient Exposure to Contrast Agent and Radiation

High Growth of AI and ML in the Surgical Robots to Perform Complicated Surgeries and Improve the Experience

AI Robot in Heart Treatment Market Trends:

Increased Focus on the Technological Advancements of Robotics by the Market Players

AI Robot in Heart Treatment Market Growth Opportunities:

Increasing Number of Cardiac Patients Across the Globe Due to Change in Lifestyle

Evolution of 5G Network Technology and Increased Adoption of Advanced Technologies like AI, ML, and Robotics in the Developing Countries

As the AI Robot in Heart Treatment market is becoming increasingly competitive, it has become imperative for businesses to keep a constant watch on their competitor strategies and other changing trends in the AI Robot in Heart Treatment market. Scope of AI Robot in Heart Treatment market intelligence has proliferated to include comprehensive analysis and analytics that can help revamp business models and projections to suit current business requirements. We help our customers settle on more intelligent choices to accomplish quick business development. Our strength lies in the unbeaten diversity of our global market research teams, innovative research methodologies, and unique perspective that merge seamlessly to offer customized solutions for your every business requirement. Have Any Questions Regarding Global AI Robot in Heart Treatment Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/186484-global-ai-robot-in-heart-treatment--market Strategic Points Covered in Table of Content of Global AI Robot in Heart Treatment Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the AI Robot in Heart Treatment market

Chapter 2: Exclusive Summary and the basic information of the AI Robot in Heart Treatment Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the AI Robot in Heart Treatment

Chapter 4: Presenting the AI Robot in Heart Treatment Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region/Country 2018-2022

Chapter 6: Evaluating the leading manufacturers of the AI Robot in Heart Treatment market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2023-2028)

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, AI Robot in Heart Treatment Market is a valuable source of guidance for individuals and companies. Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/reports/186484-global-ai-robot-in-heart-treatment--market What benefits does AMA research study is going to provide?

Latest industry influencing trends and development scenario

Open up New Markets

To Seize powerful market opportunities

Key decision in planning and to further expand market share

Identify Key Business Segments, Market proposition & Gap Analysis

Assisting in allocating marketing investments

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia. Contact US : Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[semiconductor-hub]

Semiconductor Market Growth Statistics and Key Players Insights (2024-2032)

The semiconductor industry forms the backbone of modern electronics, enabling the development of cutting-edge technologies across various sectors. Semiconductors are essential components in devices such as smartphones, computers, medical equipment, and automotive systems, driving advancements in computing power, energy efficiency, and miniaturization. As demand for faster processing, lower energy consumption, and innovative applications grows, the global semiconductor industry continues to experience rapid expansion, making it one of the most critical sectors in the global economy. This industry is positioned at the heart of the digital transformation, paving the way for future innovations in artificial intelligence, 5G, and the Internet of Things (IoT).

The Semiconductor Market Size was USD 573.42 billion in 2023 and is expected to reach USD 1641.9 billion by 2032, growing at a CAGR of 12.4% over the forecast period of 2024-2032.

Future Scope

The semiconductor industry is expected to continue its upward trajectory as technological innovations push the boundaries of computing power and efficiency. Emerging technologies such as quantum computing, advanced AI algorithms, and high-performance edge computing are driving demand for more powerful and efficient semiconductor solutions. Furthermore, the increasing integration of semiconductors into renewable energy systems, autonomous vehicles, and smart cities is set to further expand the industry’s potential. Governments and private sector investments in semiconductor manufacturing, research, and development are also accelerating advancements, fostering a new era of high-performance semiconductors tailored to future needs.

Trends

Key trends reshaping the semiconductor landscape include miniaturization, increased energy efficiency, and the evolution of chip architectures. The industry is moving towards smaller, more powerful chips capable of handling complex AI workloads, 5G networks, and advanced sensors for IoT devices. The growing need for energy-efficient technologies is driving innovations in semiconductor materials, such as gallium nitride (GaN) and silicon carbide (SiC), which offer superior performance in power electronics. Additionally, advances in semiconductor packaging techniques, such as 3D stacking and system-in-package (SiP) solutions, are enabling higher performance at reduced sizes and costs.

Applications

Semiconductors are integral to various applications across industries. In consumer electronics, they power smartphones, laptops, and wearable devices, while in automotive systems, they enable autonomous driving, advanced driver-assistance systems (ADAS), and electric vehicle technologies. In healthcare, semiconductors facilitate the development of medical devices and diagnostic equipment, improving patient care through real-time monitoring and precision treatment. Additionally, the industrial sector leverages semiconductors for automation, robotics, and energy-efficient systems, driving productivity and sustainability in manufacturing processes.

Solutions and Services

The semiconductor industry offers a range of solutions and services that cater to the diverse needs of multiple sectors. These include custom chip design, fabrication, and testing services, as well as software tools for optimizing chip performance. Advanced semiconductor manufacturing facilities are evolving to meet the demand for high-volume production of next-generation chips, focusing on precision, scalability, and cost-effectiveness. Industry players are also investing in developing AI-driven solutions that enhance the design and manufacturing processes, reducing time-to-market and increasing production yield.

Key Points

Semiconductors are fundamental to the electronics industry, driving innovations in multiple sectors.

Quantum computing, AI, and 5G are key drivers of semiconductor demand.

Miniaturization and energy efficiency are leading trends in semiconductor design.

Semiconductors are critical in applications ranging from consumer electronics to autonomous vehicles and healthcare.

Industry solutions include custom chip design, AI-driven manufacturing, and scalable production technologies.

Read More Details: https://www.snsinsider.com/reports/semiconductor-market-3959 

Contact Us:

Akash Anand — Head of Business Development & Strategy

Email: info@snsinsider.com

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND)

[lomatechnology]

Exploring Cambodia AI 2024: Trends, Future, and Smart Technology

As we move further into 2024, Cambodia AI 2024 is set to witness significant advancements, shaping the future of technology in the region. The rise of AI development in Cambodia is not just a trend but a transformative force that is driving the nation’s digital economy forward. This article delves into the artificial intelligence trends in Cambodia, explores the ongoing digital transformation in 2024, and discusses the impact of AI on the local job market and industries.

The Rise of AI Development in Cambodia

AI development in Cambodia has been accelerating, thanks to increased investment and interest from both the private and public sectors. The Cambodian government’s initiatives to foster innovation and technological growth have created a fertile ground for AI to flourish. In 2024, AI is expected to play a pivotal role in various sectors, from healthcare to agriculture, enhancing efficiency and productivity across the board.

Key AI Trends Shaping Cambodia in 2024

Machine Learning and Big Data:

Machine learning is at the heart of the AI revolution in Cambodia. The ability to process vast amounts of data and extract valuable insights is transforming how businesses operate. From predicting consumer behavior to optimizing supply chains, machine learning in Cambodia is opening up new possibilities for innovation.

Robotics and Automation:

The integration of robotics in Cambodia 2024 is another significant trend. Industries such as manufacturing and logistics are increasingly adopting robotic automation to streamline operations and reduce costs. This trend is expected to grow, with AI-powered robots becoming more common in Cambodian industries.

Smart Technology and IoT:

The convergence of AI with the Internet of Things (IoT) is leading to the development of smart technology in Cambodia. From smart cities to intelligent transportation systems, AI is enabling the creation of interconnected systems that enhance the quality of life and drive economic growth.

AI in Healthcare:

AI is revolutionizing healthcare in Cambodia, providing tools for early diagnosis, personalized treatment, and efficient management of medical records. The use of AI in healthcare is expected to expand further in 2024, improving patient outcomes and reducing healthcare costs.

The Future of AI in Cambodia

Looking ahead, the future of AI in Cambodia is bright, with the potential to transform the nation’s economy and position it as a leader in Southeast Asia's digital landscape. The ongoing digital transformation in 2024 is paving the way for AI to be integrated into more aspects of everyday life, from education to public services.

AI Job Market and Industry Growth

The growth of the AI industry in Cambodia is creating new job opportunities and reshaping the job market. As businesses increasingly adopt AI technologies, there is a rising demand for skilled professionals in fields such as data science, machine learning, and AI engineering. The AI job market in Cambodia is expected to expand rapidly, offering lucrative career prospects for those with the right skills.

To meet the growing demand for AI talent, educational institutions and training centers in Cambodia are beginning to offer specialized programs in AI and related fields. This development is crucial for bridging the skills gap and ensuring that the Cambodian workforce is prepared to thrive in the AI-driven economy.

AI Integration in Cambodian Industries

Industries across Cambodia are starting to realize the benefits of AI integration. From automating routine tasks to enhancing decision-making processes, AI is being used to drive efficiency and innovation. AI automation in Cambodian industries is particularly prevalent in sectors such as manufacturing, finance, and retail, where it is helping companies stay competitive in an increasingly digital world.

Conclusion

As Cambodia AI 2024 continues to evolve, it is clear that artificial intelligence will play a central role in the nation’s digital future. With significant advancements in AI development, a growing job market, and increasing adoption across industries, Cambodia is well on its way to becoming a hub for AI innovation in Southeast Asia. Stay updated on the latest Cambodia AI 2024 news and explore how AI can transform your business by visiting Loma Technology.

[blueweave]

 India Cardiovascular Devices Market size by value at USD 0.91 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects India Cardiovascular Devices Market size to expand at a CAGR of 9.15% reaching a value of USD 1.67 billion by 2030. The Cardiovascular Devices Market in India is propelled by the escalating burden of heart failures, exacerbated by the COVID-19 pandemic. Initiatives like the National Heart Failure Biobank are playing a pivotal role in accelerating market growth by fostering research and enhancing treatment capabilities. Technological advancements, such as AI, robotics, and innovative product launches like Medtronic's Micra AV and Arctic Front, are also contributing significantly. The increasing prevalence of cardiovascular diseases among India's aging population further underscores the market's potential. As healthcare infrastructure continues to improve and awareness campaigns gain momentum, India Cardiovascular Devices Market is well-positioned to maintain a strong and steady growth trajectory.

Opportunity - Technological Advancements to Enhance Patient Care and Reduce Costs

Advancements in technology have significantly improved patient care and reduced costs in India Cardiovascular Devices Market. Innovations such as drug-eluting stents and bioresorbable alternatives enhance treatment outcomes, while cutting-edge catheterization techniques like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) provide precise coronary artery imaging for better diagnosis and treatment. The rise of robotic-assisted and minimally invasive procedures reduces recovery times and complications, offering patients quicker, less painful recoveries with fewer risks. Advanced imaging technologies, including cardiac MRI and 3D echocardiography, enable accurate diagnosis and treatment planning, while implantable devices like pacemakers and defibrillators with remote monitoring capabilities efficiently manage heart rhythm disorders. Artificial intelligence (AI) and machine learning (ML) facilitate early detection and personalized treatment plans, and telemedicine enables remote consultations, broadening access, especially in underserved areas. Wearable devices and mobile apps enhance remote cardiac monitoring and rehabilitation, while 3D printing, and nanotechnology contribute to patient-specific models and advanced drug delivery systems. These technological advancements not only improve diagnostic precision and treatment efficacy but also reduce the overall cost of care by minimizing hospital stays, complications, and post-operative care needs.

Sample Request @ https://www.blueweaveconsulting.com/report/india-cardiovascular-devices-market/report-sample

[futuristicpaintercat]

Global Angiography Equipment Market is Estimated to Witness High Growth Owing to Rising Prevalence of Cardiovascular Diseases

Angiography equipment are widely used for cardiac and vascular imaging during various cardiovascular procedures. Increasing geriatric population base prone to chronic diseases such as cardiovascular diseases has led to rising demand for angiography equipment in diagnostic and interventional procedures. Angiography provides clear visualization of blood vessels during diagnosis and treatment of vascular abnormalities. Technological advancements in angiography equipment such as flat panel detectors, automated systems and advances in guidewire and catheters design have improved imaging quality and efficacy of procedures. Rising healthcare spending coupled with increasing cases of peripheral artery disease, coronary artery disease are some of the major factors expected to boost the growth of angiography equipment market over the forecast period.

The Global Angiography Equipment Market is estimated to be valued at US$ 12.17 Bn in 2024 and is expected to exhibit a CAGR of 5.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Angiography Equipment Market are B. Braun Melsungen AG, Koninklijke Philips N.V., GE Healthcare, Cardinal Health, Siemens Healthcare Gmbh, Shimadzu Corporation, Medtronic plc, Boston Scientific Corporation, ANGIODYNAMICS, Abbot, Microport Scientific Corporation, Terumo Corporation, CURATIA MEDICAL INC., Cook Medical, Merit Medical Systems, Inc. and Applied Medical Resources Corp. The key opportunities in the market include growing healthcare infrastructure and expenditure in emerging economies, development of novel advanced angiography systems integrated with robotics, AI and newer imaging techniques. Increasing adoption of flat panel detectors and miniaturization of angiography systems is also expected to boost the growth of angiography equipment market. Market drivers The major driver driving the Global Angiography Equipment Market Growth is the rising prevalence of cardiovascular diseases across the globe. According to World Health Organization (WHO), cardiovascular diseases are the number one cause of death globally, taking an estimated 17.9 million lives each year. Conditions like coronary heart disease, cerebrovascular disease (stroke) and rheumatic heart disease accounts for most of the cardiovascular disease burden. Increasing geriatric population base prone to chronic diseases is another key factor boosting demand for angiography equipment. Rising healthcare expenditures by governments worldwide and increasing adoption of minimally invasive surgeries are some of the other drivers contributing to the growth of the market over the forecast period.

Get more insights on Global Angiography Equipment Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

[trendtrackershq]

North America: A Surgical Suite Market Powerhouse Leading Global Growth

Introduction:

The Surgical Suite Market is experiencing a period of dynamic transformation, driven by a confluence of factors that are reshaping healthcare delivery worldwide. This article delves into the factors propelling North America's dominance in this market and explores the region's future trajectory.

Download FREE Sample: https://www.nextmsc.com/surgical-suite-market/request-sample

North America: A Hub of Innovation and Market Leadership

Currently, North America holds the lion's share of the surgical suite market, and this trend is expected to continue in the coming years. Several key factors contribute to this dominance:

Advanced Healthcare Infrastructure: North America boasts a well-established and sophisticated healthcare infrastructure. This includes leading medical institutions, a highly skilled healthcare workforce, and robust research and development (R&D) capabilities. This environment fosters innovation in surgical equipment, technologies, and procedures, propelling the market forward.

High Prevalence of Chronic Diseases: A significant factor driving the North American surgical suite market is the high prevalence of chronic diseases in the region. According to the National Association of Chronic Diseases Directors, nearly 60% of adult Americans have at least one chronic disease. These conditions, including heart disease, cancer, and diabetes, often require surgical intervention, leading to a sustained demand for advanced surgical facilities.

Government Initiatives and Reimbursement Policies: Government support for healthcare infrastructure development and favorable reimbursement policies for surgical procedures in North America play a crucial role in market growth. This incentivizes hospitals and ASCs to invest in advanced surgical suites, ensuring patients have access to the latest technologies and treatment options.

Growing Focus on Minimally Invasive Surgery (MIS): The North American healthcare landscape is witnessing a growing emphasis on minimally invasive surgical (MIS) techniques. These procedures offer numerous advantages, including faster recovery times, reduced pain, and less scarring. This shift necessitates specialized surgical suites equipped with sophisticated laparoscopic and robotic surgery systems, further propelling market expansion.

Beyond Dominance: Exploring North America's Evolving Surgical Suite Landscape

While North America maintains its leadership position, the surgical suite market within the region is undergoing significant transformations:

Integration of Artificial Intelligence (AI): North American healthcare institutions are actively exploring the integration of AI into surgical suites. AI has the potential to revolutionize surgical practices by assisting surgeons with decision-making, automating repetitive tasks, and facilitating real-time data analysis during procedures.

The Rise of Telepresence Surgery: Telepresence surgery, utilizing robotic technology to allow surgeons to perform complex procedures remotely, is gaining traction in North America. This technology holds promise for improving access to specialized surgical care, particularly in underserved or geographically remote areas.

Focus on Cost-Effectiveness and Value-Based Care: The rising healthcare costs in North America are prompting a shift towards value-based care models. This approach emphasizes cost-effectiveness while ensuring optimal patient outcomes. As a result, the demand for surgical suites that optimize workflow efficiency and minimize resource utilization is on the rise.

Growing Popularity of Ambulatory Surgical Centers (ASCs): ASCs are gaining popularity in North America as they offer a cost-effective alternative to traditional hospital settings for outpatient surgical procedures. This trend is driving the development of specialized and efficient surgical suites within ASCs, catering to the specific needs of these facilities.

Challenges and Opportunities in the North American Market

Despite its dominance, the North American surgical suite market faces certain challenges:

Stringent Regulatory Landscape: The stringent regulatory environment in North America can slow down the approval process for new surgical technologies. This can hinder innovation and limit access to cutting-edge surgical equipment.

Cybersecurity Concerns: As surgical suites become increasingly reliant on digital technologies, ensuring robust cybersecurity measures to protect patient data becomes paramount. This necessitates ongoing investments in secure data management systems and protocols.

Skilled Workforce Shortages: A potential shortage of skilled surgical staff, including surgeons, nurses, and technicians, could pose a challenge in the future. Addressing this workforce gap is crucial to ensure optimal utilization of advanced surgical suites.

Inquire before buying: https://www.nextmsc.com/surgical-suite-market/inquire-before-buying

Looking Ahead: A Collaborative Future for Surgical Innovation

North America's dominance in the surgical suite market is likely to continue in the foreseeable future due to its robust healthcare infrastructure, high disease burden, and focus on innovation. However, the market landscape is evolving, with a growing emphasis on cost-effectiveness, value-based care, and the adoption of emerging technologies. By addressing existing challenges and fostering collaboration between healthcare institutions, policymakers, and technology developers, North America can solidify its position as a global leader in surgical innovation and ensure continued improvements in patient care and outcomes.

Conclusion:

North America's well-established healthcare infrastructure, high prevalence of chronic diseases, and commitment to innovation have cemented its position as a dominant force in the surgical suite market. Government support, favorable reimbursement policies, and a growing emphasis on minimally invasive surgery further contribute to market expansion. However, the future of surgical suites in North America extends beyond maintaining dominance. The integration of AI, the rise of telepresence surgery, and a focus on cost-effective, value-based care models are transforming the landscape. While challenges like stringent regulations, cybersecurity concerns, and potential workforce shortages exist, North America is well-positioned to navigate these hurdles through collaboration between healthcare providers, policymakers, and technology developers. By embracing innovation and addressing these challenges, North America can ensure its surgical suites remain at the forefront of surgical excellence, delivering improved patient outcomes and shaping the future of healthcare delivery worldwide.

[credenceresearchdotblog]

The Medical Device Technologies Market is projected to grow from USD 549,125 million in 2024 to USD 726,453.05 million by 2032, reflecting a compound annual growth rate (CAGR) of 3.56%.The medical device technologies market is a rapidly growing sector, driven by innovations that enhance patient care, improve diagnostic accuracy, and streamline medical procedures. This market encompasses a broad range of devices, from simple instruments like syringes and thermometers to sophisticated technologies such as MRI machines and surgical robots. As of 2024, the market is poised for significant expansion, driven by factors such as the increasing prevalence of chronic diseases, technological advancements, and a growing geriatric population.

Browse the full report at https://www.credenceresearch.com/report/medical-device-technologies-market

Key Market Drivers

1. Rising Prevalence of Chronic Diseases: Chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders are on the rise globally. These conditions often require ongoing monitoring and management, driving the demand for medical devices. For instance, glucose monitoring devices and insulin pumps are crucial for diabetes management, while cardiac monitoring devices are essential for patients with heart conditions.

2. Technological Advancements: Innovations in medical technology are revolutionizing patient care. The development of minimally invasive surgical techniques, advanced imaging technologies, and smart wearable devices are some examples. These advancements not only improve patient outcomes but also reduce healthcare costs by minimizing hospital stays and recovery times.

3. Aging Population: The global population is aging, with the number of people aged 60 and above expected to double by 2050. Older adults are more prone to chronic diseases and age-related conditions, necessitating a higher demand for medical devices. Mobility aids, hearing aids, and diagnostic devices tailored for older adults are in increasing demand.

4. Regulatory Approvals and Government Initiatives: Regulatory bodies like the FDA (Food and Drug Administration) and EMA (European Medicines Agency) play a crucial role in the approval and commercialization of medical devices. Governments worldwide are also implementing initiatives to improve healthcare infrastructure and access to advanced medical technologies, further boosting the market.

Segmentation of the Market

The medical device technologies market can be segmented based on device type, application, end-user, and geography.

1. By Device Type: - Diagnostic Devices: Includes imaging systems (MRI, CT scanners), in vitro diagnostic devices (blood glucose meters, pregnancy tests), and others. - Therapeutic Devices: Encompasses devices such as insulin pumps, dialysis machines, and surgical instruments. - Monitoring Devices: Includes wearable devices for continuous monitoring of vital signs, cardiac monitors, and blood pressure monitors.

2. By Application: - Cardiology - Orthopedics - Neurology - Respiratory - Others (Ophthalmology, Dermatology, etc.)

3. By End-User: - Hospitals and Clinics - Home Healthcare - Ambulatory Surgical Centers (ASCs) - Diagnostic Centers

4. By Geography: - North America - Europe - Asia-Pacific - Latin America - Middle East & Africa

Trends and Innovations

Several trends and innovations are shaping the medical device technologies market:

1. Wearable Medical Devices: Wearable technology is revolutionizing the way health data is collected and monitored. Devices like smartwatches and fitness trackers equipped with health monitoring features are gaining popularity. These devices enable continuous monitoring of vital signs and physical activity, providing valuable data for both patients and healthcare providers.

2. Artificial Intelligence (AI) and Machine Learning: AI and machine learning are transforming diagnostics and treatment planning. AI-powered imaging systems can analyze medical images with high accuracy, aiding in early disease detection. Machine learning algorithms are also used to develop predictive models for patient outcomes, improving personalized medicine.

3. Telemedicine and Remote Monitoring: The COVID-19 pandemic accelerated the adoption of telemedicine and remote monitoring solutions. These technologies allow patients to receive medical care from the comfort of their homes, reducing the burden on healthcare facilities and improving access to care in remote areas.

4. 3D Printing: 3D printing technology is being used to create customized medical devices, implants, and prosthetics. This technology allows for precise customization, improving the fit and function of these devices, and enhancing patient outcomes.

Challenges

Despite the promising growth, the medical device technologies market faces several challenges:

1. Regulatory Hurdles: The stringent regulatory requirements for medical devices can delay the approval and commercialization of new technologies. Ensuring compliance with these regulations is a significant challenge for manufacturers.

2. High Costs: The development and production of advanced medical devices involve substantial costs, which can be a barrier for both manufacturers and healthcare providers. Ensuring affordability while maintaining quality is a critical challenge.

3. Cybersecurity Risks: With the increasing integration of digital technologies in medical devices, cybersecurity has become a major concern. Ensuring the security of patient data and preventing unauthorized access to medical devices are crucial.

Key Player Analysis

Abbott Laboratories

Boston Scientific Corporation

Baxter International, Inc.

Medtronic plc

Cardinal Health Inc.

F. Hoffmann-La Roche Ltd.

GE Healthcare

Johnson & Johnson

Siemens Healthineers

Smith & Nephew plc

Stryker Corporation

Koninklijke Philips N.V.

Segments:

Based on Device Type:

In Vitro Diagnostic (IVD) Devices

Cardiology Devices

Diagnostic Imaging Devices

Orthopedic Devices

Ophthalmology Devices

Endoscopy Devices

Diabetes Care Devices

Wound Management Devices

Kidney/Dialysis Devices

Anesthesia and Respiratory Care Devices

Others

Based on End-user:

Academics & Research

Hospitals

Clinics

Diagnostic Centers

Ambulatory Surgical Centers

Others

Based on the Geography:

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

[deeptech1550]

Exploring the Boundless Potential of DEVIKA AI: Revolutionizing Artificial Intelligence

In the ever-evolving landscape of artificial intelligence (AI), one name stands out prominently: DEVIKA AI. This cutting-edge AI platform has garnered significant attention for its revolutionary capabilities and transformative impact across various industries. Harnessing the power of advanced algorithms, machine learning, and natural language processing, DEVIKA AI is reshaping the way businesses operate, revolutionizing customer experiences, and driving innovation to unprecedented heights.

DEVIKA AI: Unveiling the Technology

At the heart of DEVIKA AI lies a sophisticated array of technologies designed to emulate human cognitive abilities and surpass conventional AI systems. With its neural networks and deep learning algorithms, DEVIKA AI can analyze vast amounts of data, recognize patterns, and make intelligent decisions with remarkable accuracy and efficiency.

The platform's natural language processing (NLP) capabilities enable it to comprehend and generate human-like text, facilitating seamless communication and interaction between humans and machines. Additionally, DEVIKA AI's machine learning models continuously improve and adapt to new information, enhancing performance and predictive capabilities over time.

Applications Across Diverse Industries

DEVIKA AI's versatility and adaptability make it invaluable across a wide range of industries, from healthcare and finance to retail and manufacturing. Let's delve into some of the notable applications of DEVIKA AI in various sectors:

Healthcare: In the healthcare sector, DEVIKA AI is revolutionizing patient care, diagnosis, and treatment. Through advanced medical imaging analysis, predictive analytics, and personalized medicine, DEVIKA AI helps healthcare professionals make informed decisions, improve outcomes, and optimize resource allocation.

Finance: DEVIKA AI is transforming the financial services industry by automating tasks, detecting fraudulent activities, and enhancing customer experiences. From algorithmic trading and risk management to chatbot-based customer support, DEVIKA AI enables financial institutions to operate more efficiently and effectively in an increasingly digital world.

Retail: In the retail sector, DEVIKA AI is reshaping the customer journey, from personalized recommendations and virtual shopping assistants to inventory management and supply chain optimization. By analyzing consumer behavior and market trends in real-time, DEVIKA AI empowers retailers to deliver tailored experiences and drive sales growth.

Manufacturing: DEVIKA AI is driving innovation and efficiency in the manufacturing sector through predictive maintenance, quality control, and autonomous robotics. By optimizing production processes and minimizing downtime, DEVIKA AI helps manufacturers improve productivity, reduce costs, and enhance competitiveness in global markets.

Education: DEVIKA AI is revolutionizing education by personalizing learning experiences, automating administrative tasks, and providing intelligent tutoring systems. Through adaptive learning algorithms and virtual classrooms, DEVIKA AI empowers educators to cater to individual student needs and enhance learning outcomes.

The Ethical and Social Implications of DEVIKA AI

While DEVIKA AI offers unprecedented opportunities for progress and innovation, it also raises important ethical and social considerations that cannot be ignored. As AI systems become increasingly autonomous and pervasive, concerns about data privacy, algorithmic bias, and job displacement have come to the forefront.

Ensuring transparency, accountability, and fairness in AI decision-making is crucial to mitigating these risks and building trust among users and stakeholders. Furthermore, proactive measures must be taken to address the potential impact of AI on employment, education, and societal dynamics.

Conclusion

In conclusion, DEVIKA AI represents a paradigm shift in the field of artificial intelligence, offering unparalleled capabilities and transformative potential across diverse industries. From healthcare and finance to retail and manufacturing, DEVIKA AI is revolutionizing how businesses operate, innovate, and engage with customers.

However, as we embrace the limitless possibilities of DEVIKA AI, we must also remain vigilant about its ethical and social implications. By fostering collaboration, dialogue, and responsible AI governance, we can harness the full potential of DEVIKA AI while safeguarding the interests and values of society as a whole.

With its groundbreaking technology and visionary approach, DEVIKA AI continues to push the boundaries of what's possible in the realm of artificial intelligence, inspiring innovation and shaping the future of humanity.

[reportprimerahul]

Percutaneous Puncture Surgery Robot Market Size, Type, segmentation, growth and forecast 2023-2030

Percutaneous Puncture Surgery Robot Market

The Percutaneous Puncture Surgery Robot Market is expected to grow from USD 2.00 Billion in 2022 to USD 3.40 Billion by 2030, at a CAGR of 6.80% during the forecast period.

Percutaneous Puncture Surgery Robot Market Size

Percutaneous Puncture Surgery Robot is a medical robot that is used in minimally invasive procedures to puncture organs such as the prostate, lung, kidney, and pancreas for various applications including cancer treatment. The global market research report for this robot is segmented based on type, application, region, and market players such as Biobot, NDR, iSYS Medizintechnik, Perfint, and Perfint Healthcare. Regulatory and legal factors specific to market conditions, including government policies, rules, and regulations, also play a key role in the growth of the market. The report covers market trends, growth factors, challenges, opportunities, and competitive landscape analysis of the Percutaneous Puncture Surgery Robot market. The North American, Asian Pacific, Middle Eastern, African, Australian, and European markets are studied in detail to provide insights into market demand, supply, and revenue. This report also provides information on market share, market size, and future growth potential of the market.

Percutaneous Puncture Surgery Robot Market Key Player

Biobot

NDR

iSYS Medizintechnik

Perfint

Perfint Healthcare

Buy Now & Get Exclusive Discount on this https://www.reportprime.com/enquiry/request-discount/10428

Percutaneous Puncture Surgery Robot Market Segment Analysis

The Percutaneous Puncture Surgery Robot market has been gaining traction in recent years, driven by a variety of factors. One key factor is the increasing prevalence of chronic diseases, such as diabetes and heart disease, which often require frequent and accurate needle injections. Meanwhile, the aging population in many parts of the world is fueling demand for more precise and minimally invasive surgical procedures.

The market for Percutaneous Puncture Surgery Robots is also being driven by technological advancements. Robots in this space are becoming increasingly intuitive and advanced, with features such as real-time imaging and automatic needle adjustment. As the technology continues to improve, these robots are expected to become even more precise and efficient, further expanding their potential use cases.

One of the latest trends in the Percutaneous Puncture Surgery Robot market is the integration of artificial intelligence (AI) and machine learning (ML) algorithms. These technologies are being used to improve the speed and accuracy of robotic needle placement, as well as to detect and prevent complications such as bleeding. As more research is done in this field, we can expect to see even more advanced AI/ML-powered surgical robots emerge.

However, there are also a number of challenges facing the Percutaneous Puncture Surgery Robot market. One major challenge is the cost of these devices. While the technology is highly effective, it can be expensive to develop and implement, which may limit access to patients who need it most. At the same time, there is a shortage of skilled surgeons who are trained to use these robots, which could hinder adoption.

In conclusion, the Percutaneous Puncture Surgery Robot market is poised for growth in the coming years, driven by a combination of factors including increasing prevalence of chronic diseases, technological advancements, and advancements in AI/ML algorithms. While there are still challenges facing the market, such as cost and surgeon training, we expect that continued innovation and investment will overcome these obstacles and enable this technology to reach even more patients in need.

This report covers impact on COVID-19 and Russia-Ukraine wars in detail.

Purchase This Report: https://www.reportprime.com/checkout?id=10428&price=3590

Market Segmentation (by Application):

Lung Cancer

Breast Cancer

Prostate Cancer

Information is sourced from www.reportprime.com

[businesspr]

How Technology is Affecting the AI Robot in Heart Treatment Market: Implications for Businesses 2023

AI Robot in Heart Treatment Market Global Industry Research Report provides market size, share, industry growth, development trends, business ideas, and forecasts by 2031. Scenarios and useful business decisions.This report provides a detailed analysis of subjective, comprehensive research as well as quantitative perspectives from key manufacturers. It also includes in-depth information about…

[techscimarketresearch]

Robotics Market to Grow at a CAGR of 4.91 % until 2026 | TechSci Research

Increase in the demand for automated systems and safety concerns for different online platforms to boost the global robotics market through 2026.

According to TechSci Research report, “Global Robotics Market By Component (Hardware and Software), By Type (Articulated, Cartesian, SCARA, Cylindrical and Others), By End User (Healthcare, Media & Entertainment, Aerospace & Defense, Logistics, Automotive and Others), By Region, Competition, Forecast & Opportunities, 2016-2026’’, the Global Robotics Market is projected to cross USD68.246 billion by 2026 at a CAGR of 4.91%, on account of the growing demand for robotic systems in defense for unmanned missions and the developing research activities linked with new robotic product launches. Moreover, the growth in the usage of robotic procedures in the healthcare sector for assisting with surgeries, public relationships, personnel care, etc. will positively influence the Global Robotics Market in the upcoming years.

Browse 107 Figures spread through 110 Pages and an in-depth TOC on "Global Robotics Market"

https://www.techsciresearch.com/report/robotics-market/7279.html

The Global Robotics Market can be segmented based on component, type, end-user and region. In terms of component, the market can be branched into hardware and software. The software segment has a market share of 50.77% in 2020 due to the high demand for different automation and simulations in the healthcare, defense, security and education sectors in growing economies. The increase in the use of robotic systems with the growth of new Artificial Intelligence (AI) technology across the world is driving the software segment of the Global Robotics Market.

On the basis of type, the market is segmented into articulated, cartesian, SCARA, cylindrical and others (spherical, delta, parallel, etc.). The articulated segment has 55.56% of the market shares in 2020 owing to more degrees of freedom than other robot types. This robotic system is designed to mimic the human arm, thus positively shaping their growth in the Global Robotics Market.

Based on End User, the market can be bifurcated into healthcare, media & entertainment, aerospace & defense, logistics, automotive and others (food & beverages, electronics, machinery, etc.). The healthcare segment accounts for the largest market share of 32.18% due to the increase in demand for the accuracy, precision and remote treatments, mainly after the COVID-19 pandemic.

In the Global Robotics Market, Asia-Pacific is the largest contributor with 35.27% of market shares in 2020. China is the largest contributing country in the region for the forecasted period, followed by South Korea, Japan, India and Australia. Being the world’s largest robotics manufacturers and exporter, China’s growing urbanization and research technologies are contributing to the country’s leading market position. Meanwhile, India is at fourth position after South Korea and Japan in terms of manufacturing robots and is growing at a quicker pace as the research and development sectors are emerging in the upcoming years.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7279

Customers can also request for 10% free customization on this report.

Sony Corporation, Midea Group Co. Ltd., Honda Motor Co. Ltd, Siemens AG, DENSO Corporation, Rockwell Automation Inc., KION Group AG, Seiko Epson Corporation, Yamaha Motor Co. Ltd., ABB Ltd., etc. are among the leading players operating in Global Robotics Market. Companies operating in the market are using organic strategies, partnerships and collaborations to boost their shares in Global Robotics Market. Significant players in the market are concentrating on accomplishing ideal operational expenses, upgrading the system efficiency, enhancing precision in responses, boosting productivity with high funding in R&D, and merging with small players to support in the competitive robotics market.

“Increasing technological advancements across major developed as well as developing countries coupled with an increasing demand for simulation and automation systems across the globe are boosting the Global Robotics Market. The need for manufacturing of miniature, inexpensive and energy efficient robotics solutions for a wider consumer base is a boosting factor for the market globally. Moreover, growing innovation in the design of robotics systems has also been positively influencing the market with a continuous urge for launching new products in the upcoming years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Robotics Market By Component (Hardware and Software), By Type (Articulated, Cartesian, SCARA, Cylindrical and Others), By End User (Healthcare, Media & Entertainment, Aerospace & Defense, Logistics, Automotive and Others), By Region, Competition, Forecast & Opportunities, 2016-2026’’ has evaluated the future growth potential of Global Robotics Market by providing the statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyses the emerging trends along with essential drivers, challenges and opportunities in the Global Robotics Market.

Related Report:

Global Surgical Robots Market By Component (Systems, Instruments and Accessories, Services), By Mechanism of Control (Computer Control, Direct Telemanipulator), By Application (Orthopedic Surgery, Endometriosis, General Surgery, Neurosurgery, Thoracic Surgery, Colorectal Surgery, Gynecology, Heart Surgery, Urologic Surgery and Others), By End User (Hospitals & Clinics and Ambulatory Surgical Centers), By Region, Competition, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/surgical-robots-market/4613.html

Global Telepresence Robots Market By Component (Head v/s Body), By Type (Stationary v/s Mobile), By Application (Education, Healthcare, Enterprise, Homecare, Others), By Company, By Region, Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/global-telepresence-robots-market/1319.html

About TechSci Research:

TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

TechSci Blog: https://techsciblog.com/

[techsciresearch]

Robotics Market to Grow at a CAGR of 4.91 % until 2026 | TechSci Research

Increase in the demand for automated systems and safety concerns for different online platforms to boost the global robotics market through 2026.

According to TechSci Research report, “Global Robotics Market By Component (Hardware and Software), By Type (Articulated, Cartesian, SCARA, Cylindrical and Others), By End User (Healthcare, Media & Entertainment, Aerospace & Defense, Logistics, Automotive and Others), By Region, Competition, Forecast & Opportunities, 2016-2026’’, the Global Robotics Market is projected to cross USD68.246 billion by 2026 at a CAGR of 4.91%, on account of the growing demand for robotic systems in defense for unmanned missions and the developing research activities linked with new robotic product launches. Moreover, the growth in the usage of robotic procedures in the healthcare sector for assisting with surgeries, public relationships, personnel care, etc. will positively influence the Global Robotics Market in the upcoming years.

Browse 107 Figures spread through 110 Pages and an in-depth TOC on "Global Robotics Market"

https://www.techsciresearch.com/report/robotics-market/7279.html

The Global Robotics Market can be segmented based on component, type, end-user and region. In terms of component, the market can be branched into hardware and software. The software segment has a market share of 50.77% in 2020 due to the high demand for different automation and simulations in the healthcare, defense, security and education sectors in growing economies. The increase in the use of robotic systems with the growth of new Artificial Intelligence (AI) technology across the world is driving the software segment of the Global Robotics Market.

On the basis of type, the market is segmented into articulated, cartesian, SCARA, cylindrical and others (spherical, delta, parallel, etc.). The articulated segment has 55.56% of the market shares in 2020 owing to more degrees of freedom than other robot types. This robotic system is designed to mimic the human arm, thus positively shaping their growth in the Global Robotics Market.

Based on End User, the market can be bifurcated into healthcare, media & entertainment, aerospace & defense, logistics, automotive and others (food & beverages, electronics, machinery, etc.). The healthcare segment accounts for the largest market share of 32.18% due to the increase in demand for the accuracy, precision and remote treatments, mainly after the COVID-19 pandemic.

In the Global Robotics Market, Asia-Pacific is the largest contributor with 35.27% of market shares in 2020. China is the largest contributing country in the region for the forecasted period, followed by South Korea, Japan, India and Australia. Being the world’s largest robotics manufacturers and exporter, China’s growing urbanization and research technologies are contributing to the country’s leading market position. Meanwhile, India is at fourth position after South Korea and Japan in terms of manufacturing robots and is growing at a quicker pace as the research and development sectors are emerging in the upcoming years.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7279

Customers can also request for 10% free customization on this report.

Sony Corporation, Midea Group Co. Ltd., Honda Motor Co. Ltd, Siemens AG, DENSO Corporation, Rockwell Automation Inc., KION Group AG, Seiko Epson Corporation, Yamaha Motor Co. Ltd., ABB Ltd., etc. are among the leading players operating in Global Robotics Market. Companies operating in the market are using organic strategies, partnerships and collaborations to boost their shares in Global Robotics Market. Significant players in the market are concentrating on accomplishing ideal operational expenses, upgrading the system efficiency, enhancing precision in responses, boosting productivity with high funding in R&D, and merging with small players to support in the competitive robotics market.

“Increasing technological advancements across major developed as well as developing countries coupled with an increasing demand for simulation and automation systems across the globe are boosting the Global Robotics Market. The need for manufacturing of miniature, inexpensive and energy efficient robotics solutions for a wider consumer base is a boosting factor for the market globally. Moreover, growing innovation in the design of robotics systems has also been positively influencing the market with a continuous urge for launching new products in the upcoming years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Robotics Market By Component (Hardware and Software), By Type (Articulated, Cartesian, SCARA, Cylindrical and Others), By End User (Healthcare, Media & Entertainment, Aerospace & Defense, Logistics, Automotive and Others), By Region, Competition, Forecast & Opportunities, 2016-2026’’ has evaluated the future growth potential of Global Robotics Market by providing the statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyses the emerging trends along with essential drivers, challenges and opportunities in the Global Robotics Market.

Related Report:

Global Surgical Robots Market By Component (Systems, Instruments and Accessories, Services), By Mechanism of Control (Computer Control, Direct Telemanipulator), By Application (Orthopedic Surgery, Endometriosis, General Surgery, Neurosurgery, Thoracic Surgery, Colorectal Surgery, Gynecology, Heart Surgery, Urologic Surgery and Others), By End User (Hospitals & Clinics and Ambulatory Surgical Centers), By Region, Competition, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/surgical-robots-market/4613.html

Global Telepresence Robots Market By Component (Head v/s Body), By Type (Stationary v/s Mobile), By Application (Education, Healthcare, Enterprise, Homecare, Others), By Company, By Region, Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/global-telepresence-robots-market/1319.html

About TechSci Research:

TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

TechSci Blog: https://techsciblog.com/

[pharmaphorumuk]

AZ drug hunter Garry Pairaudeau joins AI specialist Exscientia

Drug discovery firm Exscientia has beefed up its leadership team with the appointment of former AstraZeneca scientist Dr Garry Pairaudeau as its chief technology officer.

Pairaudeau – who will report directly to Exscientia chief executive Prof Andrew Hopkins – has been at AZ for 25 years, most recently as head of hit discovery with a brief covering high-throughput screening and virtual screening, computational chemistry, machine learning, and DNA-encoded libraries.

He also served as chair of AZ’s Global Chemistry Leaders Network, with responsibility for implementing strategic initiatives and collaborations, and championed developments in artificial intelligence (AI), machine learning,  physics-based computation and automation.

Pairaudeau joins Exscientia at a fertile time for the UK biotech, which specialises in applying artificial intelligence to the drug discovery process and reckons its approach can carve up to 75% off the time it takes to find preclinical candidates.

The company hit the headlines earlier this year when it started clinical trials of the first drug molecule invented entirely using AI – a potential treatment for obsessive-compulsive disorder (OCD) partnered with Sumitomo Dainippon Pharma.

It then built on that success with a $60 million third-round financing in May – led by Novo Holdings – which is being used to build out its drug pipeline.

At Exscientia, Pairaudeau will be responsible for making sure Exscientia becomes “the most efficient drug discovery organisation in the world.”

Among his past achievements was the Malcolm Campbell award from the Royal Society of Chemistry (RSC), which he shared with other scientists for the discovery of Brilinta (ticagrelor), AZ’s blockbuster antiplatelet medication which is used with aspirin to lower a patient’s chance of having another heart attack, stroke or blood clot.

“Garry has forged a long-standing impressive career that has combined real-life drug hunting with cutting edge computational and AI techniques as well as robotics”, said Hopkins.

He added that the new CTO “has the rarest of talents of both a deep understanding of the problems of drug discovery and a drive to lead the development of new AI and automation approaches to solve those problems.”

Interest in using AI and machine learning to boost efficiency of drug discovery and development has been rising as the biopharma industry is facing declining returns on investment, and desperately needs more efficient R&D methods to boost productivity.

The global market for AI in healthcare was worth $2.1 billion in 2018, with exponential growth to $36 billion predicted by 2025, at a combined annual growth rate of 50.2%, according to a recent report by finnCap.

The post AZ drug hunter Garry Pairaudeau joins AI specialist Exscientia appeared first on .

from https://pharmaphorum.com/news/az-drug-hunter-garry-pairaudeau-joins-ai-specialist-exscientia/

[ophirgottlieb]

Even Now, The Bullish Thesis for Nvidia's Future is Breathtaking

nvidia, billion, market, company, world, driving

Even Now, The Bullish Thesis for Nvidia's Future is Breathtaking

Date Published: 1-28-2018 Written by: Ophir Gottlieb This is a snippet from a CML Pro dossier. LEDE It's time for an update, yet again, on the tech gem that has its sights set on powering all of technology, and in this review we discuss several segments, with total addressable markets topping $1 trillion. It is this forward looking view of the world that justifies Nvidia's market cap -- and a potential for serious growth. CES Nvidia was added to Top Picks on 2-Jan-16 for $32.25. As of this writing it is trading at $236.66, up 591.6%. While the key note at CES was a full 90 minutes, just the first 2 minutes and 30 seconds does the trick for a primer. Here is that video, below:

BREAKOUT SESSION Even yet more revealing was CEO Jensen Huang's breakout session which can be seen through this article posted by Venture Beat. STORY But, apart from all the videos and all the forecasts, there is more news -- real news, that powers the bullish thesis for Nvidia forward. Let's talk about some details. CARS We can star with self-driving featured cars which is a nascent industry in terms of revenue, it is booming with respect to research and planned infrastructure. Here is a forecast for the self-driving featured market:

That's 134% compounded annual growth for the six years from 2015-2020 and deep learning is the secret weapon for self-driving car algorithms. And, while dozens of manufacturers of personal cars and trucks and commercial trucks are readying themselves for a fierce battle, Nvidia has a different approach. The company's strategy in this segment is to become a part of the internal workings on which all manufacturers depend. And while that sounded a little bold when we first covered Nvidia back in 2015, today it isn't bold, it's simply a matter of fact. First, the established players in this manufacturing world are already relying on Nvidia -- companies like Audi, Toyota, Mercedes-Benz, Volvo and Tesla in automotive, and companies like PACCAR, a leading global truck manufacturer with over $17 billion in sales and 23,000 employees. Here is a wonderful video that hits the high points of the commercial trucking world, and even has some cool musical scoring:

Further yet, Nvidia has a partnership with Bosch, the world's largest automotive supplier with total global sales of $73.1 billion in 2016. We also now know that 145 automotive startups around the world have chosen NVIDIA DRIVE. In total, 225 companies are currently developing with DRIVE PX. But all of this is still, unbelievably, just the tip of the iceberg. When people think of AI in the car, they tend to imagine level 4 and level 5 driving capabilities. At these levels -- 5 being the highest -- the vehicle would be capable of most driving scenarios it encounters. Level 5 would be a fully autonomous drive. But the AI advances inside the car shouldn't go unnoticed. Here is a snippet from TheStreet.com:

Mercedes-Benz unveiled its new (Mercedes Benz User Experience) MBUX infotainment system. The AI-powered system will be available in the A-Class starting next month. Nvidia has already announced a new partnership with Volkswagen (VLKAY) for its Drive IX, Nvidia's intelligence experience toolkit. In a nutshell, Nvidia's hardware gives its customers the tools necessary to build their own AI-based applications.

The point here is that it's not just hardware, but also software. Danny Shapiro, senior director of automotive at Nvidia recently said at CES:

Software is going to define so much of the user experience, the driving experience and it will continue to evolve and get better and better. New applications and new features [will be] added to your car even after it's in your driveway.

The expansiveness of AI as it pertains to the automobile, beyond self-driving, is breathtaking. Another final word for Shapiro:

AI is really at the heart of everything that's happening in the transportation space.

WHY THIS IS IMPORTANT We could go on and on with links to product announcement on Nvidia's site that are just breathtaking, but it is in fact a 40,000 foot view that we are after. While all of this sounds like a massive opportunity, and it is, the realization of this boom has barely hit Nvidia's business. Here is the revenue from the automotive sector for Nvidia:

That's just $487 million, for a company with over $9 billion in sales. But, the total addressable market (TAM), at least in Nvidia's eyes, is quite substantial:

That is $8 billion by 2025 heading to $100 billion in the future. So, you see, while the self-driving featured car world and the various other aspects of a smart car are making headlines, they are yet to hit Nvidia's bottom line. So while we can marvel at the revenue and earnings growth, which has been staggering, just this one area is in such early stages, that it is, practically speaking, rounding error as of today. STEPPING EVEN FURTHER BACK We focused on the automotive segment to make a point -- not just about Nvidia's proliferation in one segment and the potential TAM, but also the very idea of what the company is centered on. It's not about being the face of a product, it's about being the guts of every product. Wall Street was slow to pick up on Nvidia's potential early on, but that is no longer the case. Recently Bank of America Merrill Lynch raised its price target to $275. But it's the recognition that Nvidia has several business lines, that in and of themselves are substantial companies, that is starting to resonate. We covered automotive, but the data center business is also explosive. A misguide article written August 11th, 2017, by MarketWatch read Nvidia stock could pause as server growth slows down. Here is a quick snippet from that article:

While [the graphics chips designed for data centers] segment soared 175% from the same quarter a year ago, it grew only 2% on a sequential basis to $416 million.

Of course, in the earnings report that followed, Wall Street was in fact surprised, and the data center business is large enough, right now, to see substantial impact on revenue. Here is what CNBC reported:

The company reported $501 million in datacenter revenue, which includes sales of GPUs to cloud providers like Amazon Web Services, beating analyst estimates of $461 million and marking a 20 percent increase from last quarter.

And, for a chart, we turned to some cool graphics from TechCrunch, with our added emphasis on top of it:

Taking a step back, autonomous anything (cars, trucks, drones, robots) and many other trends are still small, but here is what we can expect for the pubic cloud computing platform world:

The worldwide public cloud market is forecast to rise from $154 billion this year (2017) to nearly half a trillion dollars by 2026. That market has three dominant providers:

Amazon, Microsoft, and Google purchase from Nvidia, at scale, and this business line is a winner, right now. Tencent, Alibaba, Baidu, Facebook and Oracle also rely on Nvidia chips for their clouds. In fact, on 9-27-2017 we penned Nvidia Sign Massive Deal with China's Kingpins, relating to the cloud, specifically. So, what changed? It turns out that Nvidia's newest chip, 'Volta,' has done what it claimed it will do. This is from Nvidia:

NVIDIA Volta™ is the new driving force behind artificial intelligence. Volta will fuel breakthroughs in every industry. Humanity's moonshots like eradicating cancer, intelligent customer experiences, and self-driving vehicles are within reach of this next era of AI.

And then a comment from Goldman Sachs right after the earnings call:

The ramp of Volta seems to be tracking well, and more importantly, has significant runway ahead, in our view, as a broader set of customers adopt the new architecture in the coming quarters.

But still, if you read with a careful eye, data center revenue came in at $501 million, which more than doubled from a year ago on the strong adoption of the Volta platform, but that is still 'just' $1.62 billion over the trailing twelve-months. Nvidia projects that the TAM for the data center segment to hit $30 billion by 2020 on its way to $75 billion.

Again, this is a company with just $9 billion in sales as of the last year. ARTIFICIAL INTELLIGENCE, BROADLY While all of this sounds bullish, it really, at least in Nvidia's eyes, is still barely scratching the surface. Here is a quick take from the company on its fundamental underlying technology, the GPU, and then yet more market opportunity in the broadly defined 'Artificial Intelligence' segment.

GPU computing powers the computation required for deep neural networks to learn to recognize patterns from massive amounts of data. GPU programmability gives developers flexibility in this rapidly evolving, nascent industry. We've built an end-to-end platform to advance AI, from purpose-built processors to software to fully integrated systems. We advance fundamental AI research and fuel the AI ecosystem by working closely with developers, researchers, and startups. We aim to democratize AI, so that every company in every industry can benefit from its power.

With only 10% of manufacturing tasks automated, AI will power a new wave of automation. * NVIDIA is the #1 AV platform — revolutionizing the $10T global transportation industry. * AI Cities: 1B smart cameras worldwide by 2020 will make cities safer, smarter. * AI Healthcare: AI is transforming the spectrum of care, from detection to diagnosis to treatment. GAMING All of these segments, this world that will progress, still hasn't even touched on Nvidia's largest segment which is gaming. And even that core business, is seeing truly remarkable growth. In the latest earnings report we learned that gaming revenue in the quarter was $1.56 billion, up 25% year-on-year and up 32% sequentially and the company claimed that it saw robust demand across all regions and form factors. We also learned that more than 1,200 companies are already using Nvidia's inference platform, including Amazon, Microsoft, Facebook, Google, Alibaba, Baidu, JD.com, Hi Vision and Tencent. DRONES As if all of this wasn't enough, Nvidia appears to have, a stand-alone business for drones. Accounting and auditing giant, PWC, noted that the world drone market will near $127 billion by 2020, according to Bloomberg. The drone market in general has so many charts that look like fantasy growth forecasts that it does feel a little "too good to be true," but the PWC note adds credence to those forecasts. Here are a few charts, just for some perspective, before we get the role the Nvidia hopes to play. Let's start with a chart of projections for consumer drone shipments from our friends at Statista.

There are two incredible phenomena surrounding consumer drone shipments. The first is this chart, which shows shipments growing 570% from 2016 to 2021, ultimately hitting nearly 68 million in that year alone totaling over $5 billion in sales. The second incredible phenomenon is that consumer drones are the smallest segment when compared to commercial and military. Let's turn to the commercial market -- there is where companies like Amazon would fit in.

Much like the consumer segment, this market is set to lift-off (no pun intended) right now. We're looking at a $587 million market growing to over $12 billion, or a 20-fold increase. Yes, while consumer is set to grow nearly 6x to $5 billion, this commercial market is set to grow by 20x and to $12 billion. As enormous as those growth figures are, and easily make room for several competitors to do quite well, friends, that's literally rounding error when compared to the military. Check out the size of military compared to everything else, labeled as 'civil' in the chart below:

Even further we get these projections from "Commercial and Military Drone Market Assessment and Forecasts 2016 - 2025" (note: UAV is short for "unmanned aerial vehicle"). * By 2018, UAVs will be used by nearly for every major manufacturing company to control logistics. * By 2021, UAVs will be used nearly every automobile manufacturer in metropolitan areas and along major highways to provide ubiquitous wireless coverage based on a combination of LTE, 5G, and satellite communications. Suffice it to say, the drone market is set to become a gigantic part of technology across all customer types and the demand is expected to keep growing significantly through 2027. Nvidia writes that "there's a new generation of smarter, more advanced drones and unmanned aerial vehicles (UAVs) that uses the power of deep learning algorithms to understand and react to the world around them. NVIDIA® Jetson™ is the platform that makes it possible." Here is a video from an Nvidia partner:

On September of 25th of 2017, news broke that Chinese e-commerce giant JD had selected Nvidia for drone deliveries, rescue and agricultural use. JD.com is the second-largest online retailer behind Alibaba. RISK Nvidia's market cap, as of this writing, is over $140 billion, and the company has 'just' $9 billion in sales. It is quite profitable, pays a dividend, and is growing by leaps and bounds, but still, with that valuation it better at least be 'sort of right,' about several of the markets it is pursuing for the stock to rise. CONCLUSION It's head spinning -- all of it. Each segment seems too good to be true, and who knows, maybe it is, or at least, maybe some of them will not pan out. But, the idea that Nvidia is hitting a wall, or that growth is finally tapering, is likely false -- if you believe the company, at least. There is so much room for growth that all we can do is listen to earnings calls, and watch the world as we know it evolve. If Nvidia is right, or even if it is 'partially' right, this entity may well become the most important and powerful technology company in the world. SEEING THE FUTURE It's understanding technology that gets us an edge on finding the gems like Nvidia, when they are small and under appreciated, that can turn into the 'next Apple,' or 'next Amazon,' where we must get ahead of the curve. This is what CML Pro does. Each company in our 'Top Picks' has been selected as a future crown jewel of technology. Market correction or not, recession or not, the growth in these areas is a near certainty. We are Capital Market Laboratories. Our research sits next to Goldman Sachs, JP Morgan, Barclays, Morgan Stanley and every other multi billion dollar institution as a member of the famed Thomson Reuters First Call. But while those people pay upwards of $2,000 a month on their live terminals, we are the anti-institution and are breaking the information asymmetry. The precious few thematic top picks for 2018, research dossiers, and alerts are available for a limited time at an 80% discount for $19/mo. Join Us: Discover the undiscovered companies that will power technology's future. As always, control risk, size appropriately and use your own judgment, aside from anyone else's subjective views, including my own. Thanks for reading, friends. The author is long shares Nvidia at the time of this writing. Legal The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. Capital Market Laboratories (“The Company”) does not engage in rendering any legal or professional services by placing these general informational materials on this website. The Company specifically disclaims any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if we have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses. The Company make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that The Company endorses, sponsors, promotes or is affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated.

[preciousmetals0]

2 Buys for the Coronavirus-Fueled Telemedicine Trend

2 Buys for the Coronavirus-Fueled Telemedicine Trend:

Story Highlights:

Telemedicine use is through the roof with the COVID-19 crisis — proving it’s both a promising health care alternative and profitable investment.

Next-gen telehealth tools — artificial intelligence and robotics — are signs of Paul Mampilly’s America 2.0 prediction.

Here are two ways to tap the telemedicine market before it soars a whopping 240%.

I’m going on my third week of social distancing. And what I’ve realized is: I hardly ever need to leave my house these days.

I watch movies streamed directly to my TV. I order groceries, and they are delivered directly to my doorstep. I even have “digital happy hours” with my tennis buddies through video chat.

Now I don’t even need to leave to go to the doctor.

COVID-19 is ushering in a new era in American health care, showcasing both the promise and profitability of telemedicine.

In fact, this critical new medical trend is experiencing a defining moment. Doctors and hospitals across the country are embracing it:

At Thomas Jefferson University Hospital in Philadelphia, patients who show up at the emergency room with COVID-19 symptoms are handed a mask and an iPad. In an isolation room, they video chat with a nurse practitioner who evaluates their symptoms and treatment — remotely.

In Concord, New Hampshire, Hospital Medical Group has suspended office visits and ramped up its telehealth consultations. As of last week, 1,100 telemedicine visits had been completed and another 1,200 scheduled.

Telemedicine companies — offering physician visits for $50 to $75 — are frantically trying to hire hundreds of doctors to keep up with the surge in patients.

In addition, the White House has loosened Medicare restrictions to increase the use of telemedicine.

It’s been a long time coming. But the COVID-19 crisis is demonstrating how effective telemedicine is.

That tells me it will continue to grow long after the coronavirus.

Even before COVID-19, telemedicine was projected to grow by nearly 240% over the next five years — to become a $130 billion industry by 2025, up from $38.3 billion in 2018, according to Global Market Insights.

Now, those numbers are almost certain to go through the roof.

Rising Use + Insurance Coverage = Massive Growth

Telemedicine is not new.

In fact, more than half of American physicians are already using some form of the technology with some of their patients. Sixty-nine percent expect to use it within a year, according to surveys by PwC and American Well.

Until the outbreak, most insurance policies only offered limited coverage to older, rural patients with limited access to nearby health care facilities.

But that’s changing — rapidly.

Insurers are reversing course to embrace this technology.

One of my tennis buddies, Arthur Brand, has been using telemedicine video chats in his practice for years as a psychologist. He says his e-consults have increased exponentially in the past month:

Now, in a time of unprecedented uncertainty, social distancing and staying home for extended time there is a great risk for developing and exacerbating mental health and relationship problems. Telehealth is a medical necessity.

So the telemedicine market is really heating up. And this is great news for patients and doctors alike. It’s cheaper, more convenient and efficient than office visits — and far less risky right now.

Jefferson Hospital reports that about 20 doctors fielded more than 1,200 telemedicine calls in one day last week!

The telehealth trend is a terrific opportunity for savvy investors who put their money where their health care is headed.

Keep in mind, what we’re seeing with COVID-19 is just the tip of the iceberg of telemedicine’s reach and potential.

The latest applications go beyond simply chatting with your doctor via video. The next generation features artificial intelligence (AI), better remote sensors and new diagnostic techniques that key into a patient’s unique symptoms and genetics. For instance:

Chatbots are offering an online AI-robotic “therapist.” One study found people who chatted with one had a 45% reduction in depression and were 10 times more likely to take their medications.

New technology built into consumer electronics such as smartwatches can alert doctors to a patient’s medical needs, such as detecting a heart problem that triggers a doc to reach out by phone within minutes.

Genetic testing is driving new AI-telehealth platforms that allow patients to consult with specialists remotely for more personalized care based on their DNA.

All of these telehealth advancements point to a major boom. And now is the time to jump in.

2 Ways to Profit From the Telemedicine Revolution

We are entering a new era in precision medicine that is more accurate and affordable than the nation’s existing “one size fits all” health care system.

This is exactly what Paul calls America 2.0 — the Fourth Industrial Revolution. Our Bold Profits mega trends are merging to recreate our economy as we know it.

So, what’s the best way to profit from telemedicine, as more patients and health care providers tap into it?

First, watch Paul’s recent interview to see how America 2.0 will unfold. In it, he reveals how certain America 2.0 stocks could surge more than 1,000% — plus his No.1 stock pick for this economic upgrade.

Then, you can invest in the iShares U.S. Health Care Providers ETF (NYSE: IHF). This exchange-traded fund (ETF) holds a portfolio of 47 health care companies, many of which are already using telemedicine.

The market is ready to rebound and send new-world stocks sky-high. These two options are your way in now.

Until next week.

To your health and wealth,

Nick Tate

Senior Editorial Manager, Banyan Hill Publishing

[goldira01]

Story Highlights:

Telemedicine use is through the roof with the COVID-19 crisis — proving it’s both a promising health care alternative and profitable investment.

Next-gen telehealth tools — artificial intelligence and robotics — are signs of Paul Mampilly’s America 2.0 prediction.

Here are two ways to tap the telemedicine market before it soars a whopping 240%.

I’m going on my third week of social distancing. And what I’ve realized is: I hardly ever need to leave my house these days.

I watch movies streamed directly to my TV. I order groceries, and they are delivered directly to my doorstep. I even have “digital happy hours” with my tennis buddies through video chat.

Now I don’t even need to leave to go to the doctor.

COVID-19 is ushering in a new era in American health care, showcasing both the promise and profitability of telemedicine.

In fact, this critical new medical trend is experiencing a defining moment. Doctors and hospitals across the country are embracing it:

At Thomas Jefferson University Hospital in Philadelphia, patients who show up at the emergency room with COVID-19 symptoms are handed a mask and an iPad. In an isolation room, they video chat with a nurse practitioner who evaluates their symptoms and treatment — remotely.

In Concord, New Hampshire, Hospital Medical Group has suspended office visits and ramped up its telehealth consultations. As of last week, 1,100 telemedicine visits had been completed and another 1,200 scheduled.

Telemedicine companies — offering physician visits for $50 to $75 — are frantically trying to hire hundreds of doctors to keep up with the surge in patients.

In addition, the White House has loosened Medicare restrictions to increase the use of telemedicine.

It’s been a long time coming. But the COVID-19 crisis is demonstrating how effective telemedicine is.

That tells me it will continue to grow long after the coronavirus.

Even before COVID-19, telemedicine was projected to grow by nearly 240% over the next five years — to become a $130 billion industry by 2025, up from $38.3 billion in 2018, according to Global Market Insights.

Now, those numbers are almost certain to go through the roof.

Rising Use + Insurance Coverage = Massive Growth

Telemedicine is not new.

In fact, more than half of American physicians are already using some form of the technology with some of their patients. Sixty-nine percent expect to use it within a year, according to surveys by PwC and American Well.

Until the outbreak, most insurance policies only offered limited coverage to older, rural patients with limited access to nearby health care facilities.

But that’s changing — rapidly.

Insurers are reversing course to embrace this technology.

One of my tennis buddies, Arthur Brand, has been using telemedicine video chats in his practice for years as a psychologist. He says his e-consults have increased exponentially in the past month:

Now, in a time of unprecedented uncertainty, social distancing and staying home for extended time there is a great risk for developing and exacerbating mental health and relationship problems. Telehealth is a medical necessity.

So the telemedicine market is really heating up. And this is great news for patients and doctors alike. It’s cheaper, more convenient and efficient than office visits — and far less risky right now.

Jefferson Hospital reports that about 20 doctors fielded more than 1,200 telemedicine calls in one day last week!

The telehealth trend is a terrific opportunity for savvy investors who put their money where their health care is headed.

Keep in mind, what we’re seeing with COVID-19 is just the tip of the iceberg of telemedicine’s reach and potential.

The latest applications go beyond simply chatting with your doctor via video. The next generation features artificial intelligence (AI), better remote sensors and new diagnostic techniques that key into a patient’s unique symptoms and genetics. For instance:

Chatbots are offering an online AI-robotic “therapist.” One study found people who chatted with one had a 45% reduction in depression and were 10 times more likely to take their medications.

New technology built into consumer electronics such as smartwatches can alert doctors to a patient’s medical needs, such as detecting a heart problem that triggers a doc to reach out by phone within minutes.

Genetic testing is driving new AI-telehealth platforms that allow patients to consult with specialists remotely for more personalized care based on their DNA.

All of these telehealth advancements point to a major boom. And now is the time to jump in.

2 Ways to Profit From the Telemedicine Revolution

We are entering a new era in precision medicine that is more accurate and affordable than the nation’s existing “one size fits all” health care system.

This is exactly what Paul calls America 2.0 — the Fourth Industrial Revolution. Our Bold Profits mega trends are merging to recreate our economy as we know it.

So, what’s the best way to profit from telemedicine, as more patients and health care providers tap into it?

First, watch Paul’s recent interview to see how America 2.0 will unfold. In it, he reveals how certain America 2.0 stocks could surge more than 1,000% — plus his No.1 stock pick for this economic upgrade.

Then, you can invest in the iShares U.S. Health Care Providers ETF (NYSE: IHF). This exchange-traded fund (ETF) holds a portfolio of 47 health care companies, many of which are already using telemedicine.

The market is ready to rebound and send new-world stocks sky-high. These two options are your way in now.

Until next week.

To your health and wealth,

Nick Tate

Senior Editorial Manager, Banyan Hill Publishing